Lisbon – 16 June 2017 Biosimilar medicines: Recognising that biosimilar medicines can vastly improve access to biological medicines, the IGBA […]
Latest Data Shows the Need to Promote Biosimilar and Value Added Medicines for Better Health
Blog
Change is good.
Change is good. A former chairman of the Generic Medicines Trade Association, Muhammad Bodhania, is a pioneer in the pharmaceutical […]
Flucloxacillin – getting the right antibiotic to the right patient, at the right time
Summary Responsible prescription of antibiotics results in better patient outcomes and reduced antibiotic resistance. Content According to the World […]
Oethmaan Biosims – Providing Affordable and Accessible Medicines in South Africa
Summary Oethmaan Biosims is one of the newest pharmaceutical companies to emerge on the SA landscape. Content Oethmaan Biosims […]
Latest Data Shows the Need to Promote Biosimilar and Value Added Medicines for Better Health
Prepared do an dissuade be so whatever steepest. Yet her beyond looked either day wished nay. By doubtful disposed do juvenile an.
